Now, with four new agents approved in the last two years and two promising agents in the pipeline, therapy selection and potential outcomes are changing.
Jeannette Y. Wick, RPh, MBA
Advertisement
Articles by Jeannette Y. Wick, RPh, MBA
Advertisement
Latest Updated Articles
New Therapies for Prostate Cancer: The PracticalitiesPublished: May 15th 2012 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
2
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
3
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
4
FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma
5